Seattle, WA (PRWEB) March 26, 2013
The Chris Elliott Fund, a brain tumor patient advocacy organization, announces their newest educational webinar on resources available to brain tumor patients regarding insurance and financial challenges. The webinar titled “A Brain Tumor Patient's Guide to Insurance & Financial Resources, Part 2” focuses on case scenarios that brain tumor patients’ face in regards to being underinsured, uninsured, or facing mounting medical expense debt. The webinar will also discuss The Affordable Care Act, clinical trials and insurance coverage for these trials.
This webinar is offered free of charge on March 28th, 2013 at 11am PDT. Registration is now open at: http://bit.ly/BrainsMatterWeb3, more information is available at the Chris Elliott Fund website.
Webinar coordinator and Chris Elliott Fund Health Information Concierge, Maria Barrett says “brain tumor patients can face numerous challenges during the stages of their treatment, sometimes affecting extended family and friends. We would like to discuss important steps to take when facing these types of challenges and provide real examples of situations brain tumor patients have faced. Our goal is to offer this information to help patients, caregivers and families navigate these potential roadblocks and make more informed decisions in their brain tumor journey. This is meant to be a starting point, arming you with the steps to take to learn more.”
This webinar is the third installment of their year-long Brains Matter Webinar Series offering unique educational information to help brain tumor patients along their journey of treatment. The series of webinars features several experts in the field of brain tumor/brain cancer research, treatment and care.
The Brains Matter Webinar Series information is gathered from a survey of international panel of experts on the CEF’s medical advisory board. These webinars are small scale, virtual meetings offering brain tumor patients a community of caregivers, experts and survivors all working towards the goal to end brain cancer. The Chris Elliott Fund is able to offer these vital services to brain tumor patients and caregivers through the generous support from Genentech, a biotechnology company based in San Francisco, and member of the Roche Group.
About the Patient Advocate Foundation:
The Patient Advocate Foundation is a national non-profit organization that serves as an active liaison between the patient and their insurer, employer and/or creditors to resolve insurance, job retention and/or debt crisis matters relative to their diagnosis through case managers, doctors and attorneys. The Patient Advocate Foundation seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability.
About the Cancer Legal Resource Center:
The CLRC operates as part of with the Disability Rights Legal Center, and is a center that provides free information and resources on cancer-related legal issues to survivors, caregivers, health care professionals, employers and others dealing with cancer. The CLRC provides information and education about cancer-related legal issues to the public through its national telephone assistance line. The CLRC also conducts national education and outreach programs for community groups, employers and healthcare professionals and is actively involved in community activities to raise public awareness of cancer-related legal and public policy issues. In September 2012, the CLRC assisted its 45,000th caller on the Telephone Assistance Line (866-THE-CLRC). Since its founding in 1997, the CLRC remains unique, providing invaluable cancer-related legal information and resources to people nationwide.
About the Chris Elliott Fund:
The Chris Elliott Fund (CEF) is a patient advocacy organization and national 501(c)(3) non-profit with corporate offices in Seattle, Washington, with goals to end brain cancer through education, advocacy, awareness and support. Established in 2002, CEF has grown to provide support nationally for brain cancer and brain tumor patients seeking guidance, advice, and assistance to demystify finding the absolute best course of treatment for their brain cancer or brain tumor. The organization and its advocates, on average, serve 500-800 patients and caregivers per month, free of charge. If we can help, please contact us at WeCare(at)EndBrainCancer(dot)com.